Zhuting Hu

Dana-Farber Cancer Institute — United States

Immunology and Microbiology · Life Sciences

12h-index6.0kcitations26works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(14), CAR-T cell therapy research(10), Immune Cell Function and Interaction(9), Cytomegalovirus and herpesvirus research(7), T-cell and B-cell Immunology(6)

Publications26 total

Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma
Nature Medicine·2021· 483 citedOpen Access
Mechanism of EBV inducing anti-tumour immunity and its therapeutic use
Nature·2020· 83 citedOpen Access
Intratumoral T cell response detected after personal neoantigen vaccine in a phase Ib glioblastoma trial
Nature·2020
Automated Flow Synthesis of Tumor Neoantigen Peptides for Personalized Immunotherapy
Scientific Reports·2020· 30 citedOpen Access
Abstract A010: Personalized neoantigen-targeting vaccines for high-risk melanoma generate epitope spreading
Cancer Immunology Research·2019· 2 cited
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Nature·2018· 1.4k citedOpen Access
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
RePEc: Research Papers in Economics·2018· 3 citedOpen Access
A cloning and expression system to probe T-cell receptor specificity and assess functional avidity to neoantigens
Blood·2018· 59 citedOpen Access
Abstract 5387: Novel targeted single-cell TCR sequencing method used for analysis of a T cell infiltrate from a glioblastoma patient
Cancer Research·2018
Abstract 5631: Personal neoantigen-targeting vaccination generates neoepitope-specific T cell responses in tumors of patients with glioblastoma
Cancer Research·2018· 7 cited
Detecting neoepitope-specific intra-tumoral T cell responses in a glioblastoma patient treated with personal neoantigen vaccine
The Journal of Immunology·2018
Erratum: Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanoma
Nature·2018· 31 citedOpen Access
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Nature reviews. Immunology·2017· 1.0k citedOpen Access
Defining the Diversity and Specificity of Neoantigen-Specific T Cells in Chronic Lymphocytic Leukemia
Blood·2017
An immunogenic personal neoantigen vaccine for patients with melanoma
Nature·2017· 2.8k citedOpen Access
Abstract PR02: A personalized neoantigen vaccine in patients with high risk melanoma
Cancer Immunology Research·2016
Functional Heterogeneity in the CD4+ T Cell Response to Murine γ-Herpesvirus 68
The Journal of Immunology·2015· 34 citedOpen Access
Functional heterogeneity and helper roles of CD4+T cells in antiviral immunity
2015
CD4+ T-cell dependence of primary CD8+ T-cell response against vaccinia virus depends upon route of infection and viral dose
Cellular and Molecular Immunology·2014· 26 citedOpen Access
MCL1 Enhances the Survival of CD8 <sup>+</sup> Memory T Cells after Viral Infection
Journal of Virology·2014· 9 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Derin B. Keskin(15), Catherine J. Wu(15), Patrick A. Ott(13), Nir Hacohen(13), Sachet A. Shukla(12), Wandi Zhang(10), Oriol Olive(10), Donna Neuberg(10), Edward F. Fritsch(10), Jing Sun(9), Kai W. Wucherpfennig(9), Annabelle Anandappa(8), Kenneth J. Livak(8), Edward J. Usherwood(8), Anita Giobbie‐Hurder(7), Jonathan Stevens(7), Jerome Ritz(7), Shuqiang Li(6), William J. Lane(6), Heather Daley(6)